Abstract:Background: Cancer cells undergo global reprogramming of cellular metabolism to satisfy demands of energy and biomass during proliferation and metastasis. Computational modeling of genome-scale metabolic models is an effective approach for designing new therapeutics targeting dysregulated cancer metabolism by identifying metabolic enzymes crucial for satisfying metabolic goals of cancer cells, but nearly all previous studies neglect the existence of metabolic demands other than biomass synthesis and trade-offs between these contradicting metabolic demands. It is thus necessary to develop computational models covering multiple metabolic objectives to study cancer metabolism and identify novel metabolic targets. Methods: We developed a multi-objective optimization model for cancer cell metabolism at genome-scale and an integrated, data-driven workflow for analyzing the Pareto optimality of this model in achieving multiple metabolic goals and identifying metabolic enzymes crucial for maintaining cancer-associated metabolic phenotypes. Using this workflow, we constructed cell line-specific models for a panel of cancer cell lines and identified lists of metabolic targets promoting or suppressing cancer cell proliferation or the Warburg Effect. The targets were then validated using knockdown and over-expression experiments in cultured cancer cell lines. Results: We found that the multi-objective optimization model correctly predicted phenotypes including cell growth rates, essentiality of metabolic genes and cell line specific sensitivities to metabolic perturbations. To our surprise, metabolic enzymes promoting proliferation substantially overlapped with those suppressing the Warburg Effect, suggesting that simply targeting the overlapping enzymes may lead to complicated outcomes. We also identified lists of metabolic enzymes important for maintaining rapid proliferation or high Warburg Effect while having little effect on the other. The importance of these enzymes in cancer metabolism predicted by the model was validated by their association with cancer patient survival and knockdown and overexpression experiments in a variety of cancer cell lines. Conclusions: These results confirm this multi-objective optimization model as a novel and effective approach for studying trade-off between metabolic demands of cancer cells and identifying cancer-associated metabolic vulnerabilities, and suggest novel metabolic targets for cancer treatment.

Integration of Cancer Gene Co-Expression Network and Metabolic Network to Uncover Potential Cancer Drug Targets.

Predicting Enzyme Targets for Cancer Drugs by Profiling Human Metabolic Reactions in NCI-60 Cell Lines

A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer

Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

A Metabolism-Relevant Signature As a Predictor for Prognosis and Therapeutic Response in Pancreatic Cancer.

Integrated gene-metabolite association network analysis reveals key metabolic pathways in gastric adenocarcinoma

Pinpointing Cancer Sub-Type Specific Metabolic Tasks Facilitates Identification of Anti-cancer Targets

A Metabolic Gene Signature to Predict Breast Cancer Prognosis

Pan-cancer Characterization of Metabolism-Related Biomarkers Identifies Potential Therapeutic Targets

Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers

MMP3C: an in-silico framework to depict cancer metabolic plasticity using gene expression profiles

Pan-cancer single-cell landscape of drug-metabolizing enzyme genes

Computational dissection of the regulatory mechanisms of aberrant metabolism in remodeling the microenvironment of breast cancer

Metabolomics, metabolic flux analysis and cancer pharmacology

Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data

Pan-Cancer, Genome-Scale Metabolic Network Analysis of over 10,000 Patients Elucidates Relationship between Metabolism and Survival

New Metabolomic Insights Into Cancer

MSD-MAP: A Network-Based Systems Biology Platform for Predicting Disease-Metabolite Links

Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction

Identifying Personalized Metabolic Signatures in Breast Cancer

Identification of Cancer–associated Metabolic Vulnerabilities by Modeling Multi-Objective Optimality in Metabolism